HER2-Targeted Tyrosine Kinase Inhibitors Cause Therapy-Induced-Senescence in Breast Cancer Cells

von McDermott, Martina S. J., Conlon, Neil, Browne, Brigid C., Szabo, Adam, Synnott, Naoise C., O’Brien, Neil A., Duffy, Michael J., Crown, John, O’Donovan, Norma
Veröffentlicht in Cancers (Basel) (2019)

Gab2 regulates cytoskeletal organization and migration of mammary epithelial cells by modulating RhoA activation

von Abreu, Maria Teresa Herrera, Hughes, William E., Mele, Katarina, Lyons, Ruth J., Rickwood, Danny, Browne, Brigid C., Bennett, Haley L., Vallotton, Pascal, Brummer, Tilman, Daly, Roger J.
Veröffentlicht 2011

PP2A inhibition overcomes acquired resistance to HER2 targeted therapy

von McDermott, Martina SJ, Browne, Brigid C, Conlon, Neil T, O’Brien, Neil A, Slamon, Dennis J, Henry, Michael, Meleady, Paula, Clynes, Martin, Dowling, Paul, Crown, John, O’Donovan, Norma
Veröffentlicht in Mol Cancer (2014)

Development of acquired resistance to lapatinib may sensitise HER2-positive breast cancer cells to apoptosis induction by obatoclax and TRAIL

von Eustace, Alex J, Conlon, Neil T, McDermott, Martina S J, Browne, Brigid C, O’Leary, Patrick, Holmes, Frankie A, Espina, Virginia, Liotta, Lance A, O’Shaughnessy, Joyce, Gallagher, Clair, O’Driscoll, Lorraine, Rani, Sweta, Madden, Stephen F, O’Brien, Neil A, Ginther, Charles, Slamon, Dennis, Walsh, Naomi, Gallagher, William M, Zagozdzon, Radoslaw, Watson, William R, O’Donovan, Norma, Crown, John
Veröffentlicht in BMC Cancer (2018)